Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 5
2005 4
2006 4
2007 10
2008 17
2009 7
2010 11
2011 14
2012 14
2013 11
2014 20
2015 18
2016 19
2017 20
2018 13
2019 17
2020 10
2021 15
2022 14
2023 12
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comment.
Trock BJ. Trock BJ. J Urol. 2022 Nov;208(5):1055. doi: 10.1097/JU.0000000000002855.02. Epub 2022 Aug 10. J Urol. 2022. PMID: 35947519 No abstract available.
Reply by Authors.
Trock BJ, Jing Y, Mabey B, Sangale Z, Lenz L, Haney N, Vidal I, Glavaris SA, Guner G, Ertunc O, Kulac I, Baena Del Valle JA, Jones T, Han M, Partin AW, Cohen T, Stone S, De Marzo AM. Trock BJ, et al. J Urol. 2022 Dec;208(6):1192-1193. doi: 10.1097/JU.0000000000002922.02. Epub 2022 Dec 1. J Urol. 2022. PMID: 36349916 No abstract available.
Reply by Authors.
Rezaee ME, Pallauf M, Fletcher SA, Han M, Pavlovich CP, Cornelia Ding CK, Epstein JI, Allaf ME, Trock BJ, Singla N. Rezaee ME, et al. Among authors: trock bj. J Urol. 2024 Mar;211(3):413-414. doi: 10.1097/JU.0000000000003825.02. Epub 2024 Jan 10. J Urol. 2024. PMID: 38198586 No abstract available.
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death.
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV. Tilki D, et al. Among authors: trock bj. J Clin Oncol. 2021 Jul 10;39(20):2284-2293. doi: 10.1200/JCO.20.03714. Epub 2021 Jun 4. J Clin Oncol. 2021. PMID: 34086480
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.
Erak E, Oliveira LD, Mendes AA, Dairo O, Ertunc O, Kulac I, Baena-Del Valle JA, Jones T, Hicks JL, Glavaris S, Guner G, Vidal ID, Markowski M, de la Calle C, Trock BJ, Meena A, Joshi U, Kondragunta C, Bonthu S, Singhal N, De Marzo AM, Lotan TL. Erak E, et al. Among authors: trock bj. Mod Pathol. 2023 Oct;36(10):100247. doi: 10.1016/j.modpat.2023.100247. Epub 2023 Jun 10. Mod Pathol. 2023. PMID: 37307876
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.
Patel RA, Sayar E, Coleman I, Roudier MP, Hanratty B, Low JY, Jaiswal N, Ajkunic A, Dumpit R, Ercan C, Salama N, O'Brien VP, Isaacs WB, Epstein JI, De Marzo AM, Trock BJ, Luo J, Brennen WN, Tretiakova M, Vakar-Lopez F, True LD, Goodrich DW, Corey E, Morrissey C, Nelson PS, Hurley PJ, Gulati R, Haffner MC. Patel RA, et al. Among authors: trock bj. J Pathol. 2024 Jan;262(1):105-120. doi: 10.1002/path.6216. Epub 2023 Oct 18. J Pathol. 2024. PMID: 37850574
Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
Tosoian JJ, Trock BJ, Ballentine Carter H, Mamawala M. Tosoian JJ, et al. Among authors: trock bj. Eur Urol. 2017 Jan;71(1):e13. doi: 10.1016/j.eururo.2016.05.037. Epub 2016 Jun 13. Eur Urol. 2017. PMID: 27311363 No abstract available.
Active surveillance for low-risk prostate cancer.
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Bangma CH, et al. Among authors: trock bj. Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22878262 Review.
Editorial Comment.
Trock BJ. Trock BJ. Urology. 2017 Sep;107:73-74. doi: 10.1016/j.urology.2017.02.058. Epub 2017 Jul 13. Urology. 2017. PMID: 28712713 No abstract available.
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Singla N, Nirschl TR, Obradovic AZ, Shenderov E, Lombardo K, Liu X, Pons A, Zarif JC, Rowe SP, Trock BJ, Hammers HJ, Bivalacqua TJ, Pierorazio PM, Deutsch JS, Lotan TL, Taube JM, Ged YMA, Gorin MA, Allaf ME, Drake CG. Singla N, et al. Among authors: trock bj. Sci Rep. 2024 Jan 17;14(1):1458. doi: 10.1038/s41598-024-51889-9. Sci Rep. 2024. PMID: 38228729 Free PMC article.
212 results